Ion Beam Applications
13.74
22-November-24 11:06:40
15 minutes delayed
Stocks
+0.46
+3.46%
Today's range
13.48 - 13.80
ISIN
BE0003766806
Source
Cboe
-
IBA Business Update – Third Quarter 2021
18 Nov 2021 01:00:00 By Nasdaq GlobeNewswire
-
28 Oct 2021 01:00:00 By Nasdaq GlobeNewswire
-
IBA and RaySearch expand their partnership in proton therapy
26 Oct 2021 11:10:00 By Nasdaq GlobeNewswire
-
IBA and the University of Pennsylvania partner to advance research of ConformalFLASH® therapy
25 Oct 2021 09:00:00 By Nasdaq GlobeNewswire
-
Proton Therapy contract finalized with Advocate Radiation Oncology Affiliate in Florida
24 Oct 2021 09:00:00 By Nasdaq GlobeNewswire
-
IBA launches the world’s first online proton therapy platform
20 Oct 2021 11:00:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM
08 Oct 2021 12:50:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
01 Oct 2021 11:45:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
24 Sep 2021 12:53:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
17 Sep 2021 12:22:00 By Nasdaq GlobeNewswire
-
IBA and SCK CEN join forces to enable production of Actinium-225
15 Sep 2021 01:00:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
10 Sep 2021 12:00:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares - 20210903
03 Sep 2021 12:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
01 Sep 2021 12:50:02 By Nasdaq GlobeNewswire
-
Executives acquire a 1.16% long term interest in IBA
31 Aug 2021 00:59:59 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
27 Aug 2021 13:15:00 By Nasdaq GlobeNewswire
-
IBA Reports Half Year 2021 Results
25 Aug 2021 01:00:00 By Nasdaq GlobeNewswire
-
IBA and partners launch significant proton therapy clinical trial
24 Aug 2021 05:35:06 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
20 Aug 2021 12:10:02 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
13 Aug 2021 12:17:00 By Nasdaq GlobeNewswire